U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H34O5
Molecular Weight 390.5131
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DIGOXIGENIN

SMILES

C[C@@]12[C@H](CC[C@]1(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C5=CC(=O)OC5

InChI

InChIKey=SHIBSTMRCDJXLN-KCZCNTNESA-N
InChI=1S/C23H34O5/c1-21-7-5-15(24)10-14(21)3-4-17-18(21)11-19(25)22(2)16(6-8-23(17,22)27)13-9-20(26)28-12-13/h9,14-19,24-25,27H,3-8,10-12H2,1-2H3/t14-,15+,16-,17-,18+,19-,21+,22+,23+/m1/s1

HIDE SMILES / InChI

Molecular Formula C23H34O5
Molecular Weight 390.5131
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Digoxigenin is a 390.5 Da steroid expressed in heart, kidney, liver, adrenal gland, cerebral cortex, lung and placental tissues; Antibodies to Digoxigenin can be used to study tumor development. Bispecific antibodies (bsAbs) that bind to both tumor specific antigens on the cell surface and to haptens such as digoxigenin (Dig) can direct digoxigeninylated payloads to tumor cells. Digoxigenin is widely used as a method for generating non-radioactive probes, and is an alternative to biotinylation.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: CHEMBL614056
317.5 nM [IC50]
507.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
High-sensitivity hybridization assay for quantitation of residual E. coli DNA.
2002-05
Immunoaffinity screening with capillary electrochromatography.
2002-05
A reverse-transcription competitive PCR assay based on chemiluminescence hybridization for detection and quantification of hepatitis C virus RNA.
2002-05
Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma.
2002-04-22
Effect of developmental lead exposure on the expression of specific NMDA receptor subunit mRNAs in the hippocampus of neonatal rats by digoxigenin-labeled in situ hybridization histochemistry.
2002-04-12
Connective tissue growth factor is directly related to liver fibrosis.
2002-04-11
Multi site polyadenylation and transcriptional response to stress of a vacuolar type H+-ATPase subunit A gene in Arabidopsis thaliana.
2002-04-02
Chromosomal aberrations in benign and malignant bilharzia-associated bladder lesions analyzed by comparative genomic hybridization.
2002-03-22
Cysteine-free mutant of aequorin as a photolabel in immunoassay development.
2002-03-22
Conjugates bearing multiple formyl-methionyl peptides display enhanced binding to but not activation of phagocytic cells.
2002-03-22
Down-regulation of Lsm1 is involved in human prostate cancer progression.
2002-03-18
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
2002-03-18
Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers.
2002-03-18
Sensitive two-color whole-mount in situ hybridizations using digoxygenin- and dinitrophenol-labeled RNA probes.
2002-03
Quantitation of cucurbit yellow stunting disorder virus in Bemisia tabaci (Genn.) using digoxigenin-labelled hybridisation probes.
2002-03
Herpes-like virus detection in infected Crassostrea gigas spat using DIG-labelled probes.
2002-03
Molecular genetic evaluation of fluorescence diagnosis in bladder cancer.
2002-03
Identification to the species level of the plant pathogens Phytophthora and Pythium by using unique sequences of the ITS1 region of ribosomal DNA as capture probes for PCR ELISA.
2002-02-05
In situ detection of Bartonella henselae cells.
2002-02
Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases.
2002-02
Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status.
2002-01-07
Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA.
2002-01-01
Histone H1-mediated transfection: role of calcium in the cellular uptake and intracellular fate of H1-DNA complexes.
2002
Assessment of transcriptional gene activity in situ by application of HOPE-fixed, paraffin-embedded tissues.
2002
Identification and preliminary characterization of mouse Adam33.
2002
The detection of Bifidobacterium adolescentis by colony hybridization as an indicator of human faecal pollution.
2002
Nonradioactive labeling and detection of mRNAs hybridized onto nucleic acid cDNA arrays.
2002
Detection of single-copy genes in DNA from transgenic plants.
2002
Non-isotopic detection of Tetramicra brevifilum (Microspora) DNA in turbot tissues.
2001-12
Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo.
2001-12
Non-radioactive digoxigenin DNA labeling and immunologic detection of HSV PCR products.
2001-12
Activation of prostanoid EP(3) and EP(4) receptor mRNA-expressing neurons in the rat parabrachial nucleus by intravenous injection of bacterial wall lipopolysaccharide.
2001-11-26
Transcript quantification based on chemical labeling of RNA associated with fluorescent detection.
2001-11-15
Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer.
2001-11
Rapid parallel detection of hygienically relevant microorganisms in water samples by PCR and specific hybridization in microtiter plates.
2001-11
[Development of donor cells in chicken-duck chimeric embryos].
2001-11
Heterologous expression of acetylcholinesterase affects proliferation and glial cytoskeleton of adherent chicken retinal cells.
2001-11
Development and optimization of polymerase chain reaction-based malaria diagnostic methods and their comparison with quantitative buffy coat assay.
2001-10
Combination of PCR subtraction and cDNA microarray for differential gene expression profiling.
2001-10
Utilization of tmRNA sequences for bacterial identification.
2001-09-07
Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
2001-09
Rapid identification of Escherichia coli microcin J25 producing strains using polymerase chain reaction and colony blot hybridization.
2001-09
Molecular monitoring of Candida albicans infections in liver transplant recipients.
2001-08
BDNF increases the early expression of TRH mRNA in fetal TrkB+ hypothalamic neurons in primary culture.
2001-08
Temporal and spatial mRNA expression of bone sialoprotein and type I collagen during rodent tooth movement.
2001-08
Analysis of c-myc DNA amplification in non-small cell lung carcinoma in comparison with small cell lung carcinoma using polymerase chain reaction.
2001-06
Differentiation of porcine circovirus 1 and 2 in formalin-fixed, paraffin-wax-embedded tissues from pigs with postweaning multisystemic wasting syndrome by in-situ hybridisation.
2001-06
Advantages of in situ hybridisation over direct or indirect in situ reverse transcriptase-polymerase chain reaction for localisation of galanin mRNA expression in rat small intestine and pituitary.
2001-04
[Pathogenecity and replication of transfusion transmitted virus in liver tissue by in situ hybridization].
2001-01
Expression of exon 13 from the Ki-67 gene in human cells and tissues by digoxigenin-labelled mRNA in situ hybridization.
2001-01
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Cellular uptake and intracellular distribution of liposomal digoxigenin-labeled oligodeoxynucleotides (ODNs) at several concentrations (0.1, 0.2, an 1.0 uM) in CaSki cells were studied.
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:53:19 GMT 2025
Edited
by admin
on Mon Mar 31 19:53:19 GMT 2025
Record UNII
NQ1SX9LNAU
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DIGOXIGENIN
HSDB   MI  
Common Name English
DIGOXIGENIN [HSDB]
Preferred Name English
DIGOXIGENIN [MI]
Common Name English
DIGOXIN IMPURITY C [EP IMPURITY]
Common Name English
3.BETA.,12.BETA.,14-TRIHYDROXY-5.BETA.-CARD-20(22)-ENOLIDE
Systematic Name English
Code System Code Type Description
CAS
1672-46-4
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
MESH
D004076
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID6051778
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
HSDB
7108
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
PUBCHEM
15478
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
216-806-2
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
DRUG BANK
DB03671
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
WIKIPEDIA
DIGOXIGENIN
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
CHEBI
145797
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
MERCK INDEX
m4455
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY Merck Index
FDA UNII
NQ1SX9LNAU
Created by admin on Mon Mar 31 19:53:19 GMT 2025 , Edited by admin on Mon Mar 31 19:53:19 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE
Related Record Type Details
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP